Cargando…
TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma
SIMPLE SUMMARY: Most patients with glioblastoma (GBM) develop recurrent diseases which can be treated with different approaches. Given the aggressive and resilient nature of GBM, continued efforts to better understand GBM pathophysiology are required to discover novel targets for future therapy. The...
Autores principales: | Campolo, Michela, Lanza, Marika, Casili, Giovanna, Paterniti, Irene, Filippone, Alessia, Caffo, Maria, Cardali, Salvatore M., Puliafito, Ivana, Colarossi, Cristina, Raciti, Gabriele, Cuzzocrea, Salvatore, Esposito, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794959/ https://www.ncbi.nlm.nih.gov/pubmed/33375627 http://dx.doi.org/10.3390/cancers13010041 |
Ejemplares similares
-
Multiple mechanisms of dimethyl fumarate in amyloid β‐induced neurotoxicity in human neuronal cells
por: Campolo, Michela, et al.
Publicado: (2017) -
The Anti-Inflammatory and Antioxidant Effects of Sodium Propionate
por: Filippone, Alessia, et al.
Publicado: (2020) -
Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice
por: Casili, Giovanna, et al.
Publicado: (2020) -
Evaluating the Protective Properties of a Xyloglucan-Based Nasal Spray in a Mouse Model of Allergic Rhinitis
por: Lanza, Marika, et al.
Publicado: (2021) -
Overview on Common Genes Involved in the Onset of Glioma and on the Role of Migraine as Risk Factor: Predictive Biomarkers or Therapeutic Targets?
por: Casili, Giovanna, et al.
Publicado: (2022)